跳至主要内容
临床试验/NCT05981833
NCT05981833招募中不适用

A Randomized, Post-market Study Evaluating Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Arthrex, Inc.4 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Arthrex, Inc.
入组人数
120
试验地点
4
主要终点
The primary outcome measure is healing evaluation in MRI

研究概览

简要总结

The purpose of this study is to compare postoperative healing of large and massive rotator cuff tears with preoperative MRI confirmed fatty infiltration stage II and higher repaired with or without dermal allograft augmentation (DAA).

详细描述

The primary objective is to evaluate postoperative healing of rotator cuff repair with and without DAA.

Primary: The primary outcome measure is healing evaluation in MRI . MRI Post-Operative Assessment (Goutallier Stage and Sugaya Classification)

Secondary: The secondary outcome measures are patient-reported outcome measures from validated outcome scoring systems, including:

American Shoulder and Elbow Surgeons Score (ASES)

Single Assessment Numeric Evaluation score (SANE)

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The subject is between the ages of 30 and 75 years.
  • Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)
  • Two complete RCTs or tear size equal to or greater than 3 cm in either the anterior-posterior or medial-lateral dimension
  • Primary rotator cuff repair
  • Stage II fatty infiltration or higher of the supraspinatus or infraspinatus muscle based on preoperative MRI
  • Subject has a dual x-ray absorptiometry (DXA) or anterior posterior x-ray view of the target shoulder

排除标准

  • The Subject is unable or unwilling to sign the patient informed consent, approved by the Institutional Review Board.
  • The subject objects to the use of allograft
  • Stage I or lower fatty infiltration of the supraspinatus AND infraspinatus muscle
  • Complete full-thickness subscapularis tears of greater than the superior one third of the tendon (Lafosse grade 3 and above)
  • Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph
  • Recurrent shoulder instability
  • Corticosteroid injection in the operative shoulder within one month of surgery
  • Revision rotator cuff repair
  • Subject preoperative MRI obtained more than 12 months prior to surgery
  • Pregnant or planning to become pregnant during the study period
  • Workman's compensation case
  • Subject has conditions or circumstances that would interfere with study requirements.
  • Intraoperative exclusion criteria:
  • Partial rotator cuff repairs
  • Lafosse grade 3 or higher subscapularis tears

结局指标

主要结局

The primary outcome measure is healing evaluation in MRI

时间窗: 26 Weeks

MRI Post-Operative Assessment (Goutallier Stage and Sugaya Classification) MRI Post-Operative Assessment (Goutallier Stage and Sugaya Classification)

次要结局

  • The secondary outcome measures are patient-reported outcome measures from validated outcome scoring systems(Preop, 26 Weeks, 1 Year, 2 Year)
  • Single Assessment Numeric Evaluation score (SANE)(Preop, 26 Weeks, 1 Year, 2 Year)
  • Veterans RAND Health Survey (VR-12)(Preop, 26 Weeks, 1 Year, 2 Year)
  • Visual Analog Scale (VAS) for pain(Preop, two-week, six week, 26 Weeks, 1 Year, 2 Year)

研究者

发起方
Arthrex, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验